de Wit Jelke, Haber Travis, Hall Michelle, Bennell Kim L, Hinman Rana S, Spiers Libby, Kimp Alexander J, Dell'Isola Andrea, Harmer Alison R, van der Esch Martin, Lawford Belinda J
Radboud University, Nijmegen, the Netherlands.
The University of Melbourne, Victoria, Australia.
Musculoskeletal Care. 2025 Jun;23(2):e70110. doi: 10.1002/msc.70110.
To assess whether there is an association between total prescribed dosage of resistance exercise (volume, frequency, intensity, and duration) and change in pain and physical function in individuals with knee osteoarthritis (OA).
A systematic review with meta-regression was conducted, searching MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials until December 11, 2024. We included randomised controlled trials that compared resistance exercise for knee OA with non-exercise interventions. Meta-regression examined the association between total prescribed exercise dosage (volume × frequency × intensity × duration of the intervention) and standardised mean differences (SMDs) for change in pain and physical function. Covariates were included to attempt to reduce between-study heterogeneity.
Analysis of 14 trials (N = 1274) found no association between total prescribed resistance exercise dosage and changes in pain (slope coefficient: < 0.01 on a 0-100 scale [95% CI: < - 0.01 to < 0.01]; p = 0.18) or physical function (slope coefficient: < 0.01 on a 0-100 scale [95% CI: < - 0.01 to < 0.01]; p = 0.15). Heterogeneity was substantial (I = 73%-97%) and many trials were of unclear/high risk of bias.
No association was found between the total prescribed dosage of resistance exercise and changes in pain or function in individuals with knee OA. However, due to the limited number of trials, high heterogeneity, and overall low quality of studies, findings should be interpreted with caution.
评估膝关节骨关节炎(OA)患者的抗阻运动总处方剂量(运动量、频率、强度和持续时间)与疼痛及身体功能变化之间是否存在关联。
进行了一项包含meta回归的系统评价,检索MEDLINE、Embase和Cochrane对照试验中央注册库,检索截至2024年12月11日的文献。我们纳入了比较膝关节OA抗阻运动与非运动干预的随机对照试验。Meta回归分析了抗阻运动总处方剂量(干预的运动量×频率×强度×持续时间)与疼痛和身体功能变化的标准化均数差(SMD)之间的关联。纳入协变量以试图减少研究间的异质性。
对14项试验(N = 1274)的分析发现,抗阻运动总处方剂量与疼痛变化(斜率系数:在0 - 100量表上<0.01 [95%CI:< - 0.01至<0.01];p = 0.18)或身体功能变化(斜率系数:在0 - 100量表上<0.01 [95%CI:< - 0.01至<0.01];p = 0.15)之间无关联。异质性较大(I² = 73% - 97%),许多试验存在不明确/高偏倚风险。
未发现膝关节OA患者的抗阻运动总处方剂量与疼痛或功能变化之间存在关联。然而,由于试验数量有限、异质性高以及研究总体质量较低,研究结果应谨慎解读。